What a week at JP Morgan Healthcare! Met amazing investors and service providers, fueling Reglagene's journey in developing innovative brain therapies.

CEO Richard Austin and Director of Operations Michael Abrahamson attended Texas Life Science Forum 2023.

Drs. Suzuki, Patrón, and Gokhale present at the AACR Special Conference on Brain Cancer in Minneapolis, MN.

Reglagene’s Richard Austin was on a panel during the AZAdvances Innovation Showcase during AZBio Week.

Richard Austin and Michael Abrahamson are joined by Board Chair Lawrence Kinet, Tripp Shannon, CFA, and Jeff Koenig at Seattle’s Keiretsu Syndication Summit & Keiretsu Family Office Forum.

Dr. Richard Austin will be presenting Reglagene at the Keiretsu Family Office Forum on August 16, 2023.

Reglagene's CEO Richard Austin is attending the 2023 SNO/ASCO CNS Cancer Conference.

At BIO2023, we presented our new preclinical efficacy data demonstrating Reglagene’s medicine outperforming the standard of care treatment.

Reglagene CEO Richard Austin leads off the Alumni session of Venture Madness 2023.